Risultati della ricerca - Avraham Frisch
- Mostra 1 - 3 risultati su 3
-
1
HiDAC Consolidation in AML : Comparable Outcomes With Reduced Toxicity Using a Three‐Day Schedule ( HiDAC ‐123) Autoría: Baher Krayem, Nurit Horesh, Avraham Frisch, Tsila Zuckerman, Yishai Ofran
Pubblicazione 2025Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
2
Post‐Relapse Outcomes of Older Patients With NPM1‐Mutated AML Are Favorable With Allo Transplant in Second Remission Autoría: Avraham Frisch, Chezi Ganzel, Yishai Ofran, Baher Krayem, Arnon Haran, Vladimir Vainstein, Shlomzion Aumann, Noa Gross Even‐Zohar, Boaz Nachmias
Pubblicazione 2024Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
3
CPX‐351 +/− gemtuzumab ozogamicin as induction therapy for adult patients with newly diagnosed, favourable‐intermediate risk, FLT3‐ITD negative, AML: A pilot study Autoría: Chezi Ganzel, Avraham Frisch, Ofir Wolach, Yakir Moshe, Baher Krayem, Neta Dor, Etti Broide, Emmanuel Benayoun, Jacob M. Rowe, Yishai Ofran
Pubblicazione 2024Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso